Drug Delivery
OctoPlus obtains full rights to PolyActive drug delivery technology from IsoTis
Published in Drug Law Weekly, May 8th, 2007
OctoPlus N.V. ("OctoPlus" or the "Company") (Euronext: OCTO), the drug delivery and development company, announces today that it reached agreement with IsoTis, Inc. (NASDAQ: ISOT) to obtain additional rights to its PolyActive(tm) drug delivery technology, the technology used in OctoPlus' lead product Locteron(tm). Locteron is a controlled release formulation of interferon alfa for the treatment of chronic hepatitis C, currently in Phase IIa studies.
Under the revised agreement, OctoPlus obtains full rights to the PolyActive technology and its intellectual property in certain strategic areas, including additional applications in orthopedics. Furthermore, the contract...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-05-08)
More Articles from Drug Law Weekly
- Allergies
Allergy & Asthma Network Mothers of Asthmatics Exposes Potentially Dangerous Asthma Medications - Arthritis
Former Building Cleaner Confronts J&J About Access to Health Care, Drugs - Biotech Business
Spherix Signs Letter of Intent for the Sale of Its Information Subsidiary - Drug Development
Express Scripts' Workers' Compensation Program Increases Use of Generic Drugs - Drug Development
Recent studies from National Board of Forensic Medicine add new data to drug development - Drug Development
Texas Court Dismisses Claim of VIOXX User Who Said Merck Failed to Properly Warn of the Alleged Risks - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
